Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-09-01
2000-06-06
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514443, 514444, 514455, 514468, 548431, 548432, 549 44, 549299, 549387, A61K 3138, A61K 31335, C07D40702, C07D40902, C07D491042
Patent
active
06071946&
ABSTRACT:
A compound selected from those of formula (I): ##STR1## in which A, Y, R.sup.1, R.sup.2 and R.sup.3 are as defined in the Specification, and pharmaceutical compositions containing the same, which are useful for treating a mammal afflicted with a disorder of the melatoninergic system.
REFERENCES:
patent: 5843986 (1998-12-01), Leiseur et al.
Glennon et al. in Drug Development Research 22 25-36 (1991).
S. Conway et al. in Society for Neuroscience, 23. Item 420.11 (1997).
Ait Mansour Hamid
Delagrange Philippe
Depreux Patrick
Leclerc Ve'ronique
Lesieur Daniel
Adir et Compagnie
Richter Johann
Solola Taofiq A.
LandOfFree
Tricyclic urea compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic urea compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic urea compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2214017